| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACTH (corticotrophin) therapy in resistant primary membranous nephropathy
|
Bagchi, Soumita
|
|
2019
|
96 |
1 |
p. 250-251
|
article
|
| 2 |
Albumin assays and clinical decision-making in nephrotic syndrome patients
|
Delanghe, Joris R.
|
|
2019
|
96 |
1 |
p. 248-249
|
article
|
| 3 |
ANCA renal risk score predicts outcome in the Manchester cohort
|
Li, Anna S.
|
|
2019
|
96 |
1 |
p. 246-247
|
article
|
| 4 |
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
|
Sommerer, Claudia
|
|
2019
|
96 |
1 |
p. 231-244
|
article
|
| 5 |
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
|
Myette, James R.
|
|
2019
|
96 |
1 |
p. 104-116
|
article
|
| 6 |
A renal risk score for ANCA-associated glomerulonephritis
|
Wester Trejo, Maria A.C.
|
|
2019
|
96 |
1 |
p. 245
|
article
|
| 7 |
Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
|
Kanda, Eiichiro
|
|
2019
|
96 |
1 |
p. 8-10
|
article
|
| 8 |
ATHENA: wisdom and warfare in defining the role of de novo mTOR inhibition in kidney transplantation
|
Chadban, Steve
|
|
2019
|
96 |
1 |
p. 27-30
|
article
|
| 9 |
B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients
|
Kaundal, Urvashi
|
|
2019
|
96 |
1 |
p. 249-250
|
article
|
| 10 |
Blood pressure measurement in mice: tail-cuff or telemetry?
|
Drüeke, Tilman B.
|
|
2019
|
96 |
1 |
p. 36
|
article
|
| 11 |
Chronic kidney disease and fracture risk: a mechanistic insight
|
Sugiyama, Toshihiro
|
|
2019
|
96 |
1 |
p. 247
|
article
|
| 12 |
Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders
|
Javaugue, Vincent
|
|
2019
|
96 |
1 |
p. 94-103
|
article
|
| 13 |
Comprehensive three-dimensional analysis (CUBIC-kidney) visualizes abnormal renal sympathetic nerves after ischemia/reperfusion injury
|
Hasegawa, Sho
|
|
2019
|
96 |
1 |
p. 129-138
|
article
|
| 14 |
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
|
Schlackow, Iryna
|
|
2019
|
96 |
1 |
p. 170-179
|
article
|
| 15 |
Current status, challenges, and the role of ISN in advancement of nephrology in the Newly Independent States and Russia region
|
Tchokhonelidze, Irma
|
|
2019
|
96 |
1 |
p. 48-51
|
article
|
| 16 |
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|
Chan, Christopher T.
|
|
2019
|
96 |
1 |
p. 37-47
|
article
|
| 17 |
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome–related factor H mutation
|
Ueda, Yoshiyasu
|
|
2019
|
96 |
1 |
p. 67-79
|
article
|
| 18 |
Editorial Board
|
|
|
2019
|
96 |
1 |
p. A1
|
article
|
| 19 |
Fluid management in the critically ill
|
Vincent, Jean-Louis
|
|
2019
|
96 |
1 |
p. 52-57
|
article
|
| 20 |
Functional role of epigenetic regulation in the development of prenatal programmed hypertension
|
Liu, Yong
|
|
2019
|
96 |
1 |
p. 10-12
|
article
|
| 21 |
Gut microbiome and kidney stone disease: not just an Oxalobacter story
|
Ticinesi, Andrea
|
|
2019
|
96 |
1 |
p. 25-27
|
article
|
| 22 |
Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis
|
Miller, Aaron W.
|
|
2019
|
96 |
1 |
p. 180-188
|
article
|
| 23 |
Interstitial nephritis in immune checkpoint inhibitor therapy
|
Manohar, Sandhya
|
|
2019
|
96 |
1 |
p. 252
|
article
|
| 24 |
In this issue
|
|
|
2019
|
96 |
1 |
p. 1
|
article
|
| 25 |
Journal Club
|
|
|
2019
|
96 |
1 |
p. 5-7
|
article
|
| 26 |
Light of dawn in Melbourne: SONAR and CREDENCE
|
Nangaku, Masaomi
|
|
2019
|
96 |
1 |
p. 2-4
|
article
|
| 27 |
Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children
|
Azukaitis, Karolis
|
|
2019
|
96 |
1 |
p. 214-221
|
article
|
| 28 |
Men, mice, and blood pressure: telemetry?
|
Luft, Friedrich C.
|
|
2019
|
96 |
1 |
p. 31-33
|
article
|
| 29 |
Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases
|
Mulay, Shrikant R.
|
|
2019
|
96 |
1 |
p. 58-66
|
article
|
| 30 |
Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients
|
Lefaucheur, Carmen
|
|
2019
|
96 |
1 |
p. 189-201
|
article
|
| 31 |
Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions
|
Kuppe, Christoph
|
|
2019
|
96 |
1 |
p. 80-93
|
article
|
| 32 |
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease
|
Gansevoort, Ron T.
|
|
2019
|
96 |
1 |
p. 159-169
|
article
|
| 33 |
Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell–mediated rejection and non-adherence
|
Cherukuri, Aravind
|
|
2019
|
96 |
1 |
p. 202-213
|
article
|
| 34 |
Recognizing diversity in parietal epithelial cells
|
D’Agati, Vivette D.
|
|
2019
|
96 |
1 |
p. 16-19
|
article
|
| 35 |
Subscription Information
|
|
|
2019
|
96 |
1 |
p. A2
|
article
|
| 36 |
Table of Contents
|
|
|
2019
|
96 |
1 |
p. A3, A5, A7, A9, A11
|
article
|
| 37 |
Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?
|
Noris, Marina
|
|
2019
|
96 |
1 |
p. 13-15
|
article
|
| 38 |
The authors reply
|
Brix, Silke R.
|
|
2019
|
96 |
1 |
p. 245-246
|
article
|
| 39 |
The authors reply
|
Whitlock, Reid H.
|
|
2019
|
96 |
1 |
p. 247-248
|
article
|
| 40 |
The authors reply
|
van de Logt, Anne-Els
|
|
2019
|
96 |
1 |
p. 249
|
article
|
| 41 |
The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury
|
Peng, Qi
|
|
2019
|
96 |
1 |
p. 117-128
|
article
|
| 42 |
The Case | Acute kidney injury in an African woman with microangiopathic hemolytic anemia and HIV
|
Elabd, Hatem
|
|
2019
|
96 |
1 |
p. 253-254
|
article
|
| 43 |
The Case | An unusual cause of renal impairment and hematuria in aortic dissection
|
Lim, Cynthia C.
|
|
2019
|
96 |
1 |
p. 255-256
|
article
|
| 44 |
The choice of the assay for measuring albumin has a major impact on routine laboratory values
|
Labriola, Laura
|
|
2019
|
96 |
1 |
p. 248
|
article
|
| 45 |
The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins
|
Walther, Carl P.
|
|
2019
|
96 |
1 |
p. 22-25
|
article
|
| 46 |
The motor protein Myo1c regulates transforming growth factor-β–signaling and fibrosis in podocytes
|
Arif, Ehtesham
|
|
2019
|
96 |
1 |
p. 139-158
|
article
|
| 47 |
Under pressure—how to assess blood pressure in rodents: tail-cuff?
|
Luther, James Matthew
|
|
2019
|
96 |
1 |
p. 34-36
|
article
|
| 48 |
Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease
|
Ottlewski, Isabel
|
|
2019
|
96 |
1 |
p. 222-230
|
article
|
| 49 |
What can copeptin tell us in patients with autosomal dominant polycystic disease?
|
Bankir, Lise
|
|
2019
|
96 |
1 |
p. 19-22
|
article
|
Journal description